Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Historical Review of Brain Drug Delivery
William M. Pardridge
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Where should siRNAs go: applicable organs for siRNA drugs
In–Sook Ahn, Chanhee S. Kang, Jinju Han
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1283-1292
Open Access | Times Cited: 74
Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions
Nguyễn Thị Thanh Nhàn, Tohru Yamada, Kaori Yamada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12931-12931
Open Access | Times Cited: 50
Ultrasound trapping and navigation of microrobots in the mouse brain vasculature
Alexia Del Campo Fonseca, Chaim Glück, Jeanne Droux, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
Maj Schneider Thomsen, Kasper Bendix Johnsen, Krzysztof Kucharz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2237-2237
Open Access | Times Cited: 46
Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors’ Cancer Stem Cells: Current Knowledge and Future Perspectives
Luana Abballe, Zaira Spinello, Celeste Antonacci, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 505-505
Open Access | Times Cited: 30
Brain gene therapy with Trojan horse lipid nanoparticles
William M. Pardridge
Trends in Molecular Medicine (2023) Vol. 29, Iss. 5, pp. 343-353
Open Access | Times Cited: 27
Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective
Bivek Chaulagain, Avinash Gothwal, Richard Nii Lante Lamptey, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2710-2710
Open Access | Times Cited: 25
Mfsd2a utilizes a flippase mechanism to mediate omega-3 fatty acid lysolipid transport
Geok Lin Chua, Bryan C. Tan, Randy Y.J. Loke, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 10
Open Access | Times Cited: 23
Blood-brain barrier biomarkers
Juan F. Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, et al.
Advances in clinical chemistry (2024), pp. 1-88
Closed Access | Times Cited: 7
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Estela Pineda, Marta Domènech, Ainhoa Hernández, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 71-86
Open Access | Times Cited: 18
DNA-AgNC Loaded Liposomes for Measuring Cerebral Blood Flow Using Two-Photon Fluorescence Correlation Spectroscopy
Xiaojin Wang, Mikkel B. Liisberg, Georgia L. Nolt, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12862-12874
Closed Access | Times Cited: 15
Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders
Meenakshi Raghav, Vaishnavi Gupta, Rajendra Awasthi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104756-104756
Closed Access | Times Cited: 15
A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate
Kathleen F. Pirollo, Manish Moghe, Miaoyin Guan, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 307-326
Open Access | Times Cited: 6
A new frontier in neuropharmacology: Recent progress in natural products research for blood–brain barrier crossing
Ureña-Vacas Isabel, Aznar de la Riera M. Belén, Serrano Dolores R, et al.
Current Research in Biotechnology (2024) Vol. 8, pp. 100235-100235
Open Access | Times Cited: 6
Sounding Out the Blood–Brain Barrier
Kullervo Hynynen
New England Journal of Medicine (2024) Vol. 390, Iss. 1, pp. 82-85
Closed Access | Times Cited: 5
Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics
Patrick T. Ronaldson, Thomas P. Davis
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 1, pp. 71-89
Closed Access | Times Cited: 5
Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review
Benjamin Rodriguez, Daniel Rivera, Jack Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 300-300
Open Access | Times Cited: 5
Non-stem cell-derived exosomes: a novel therapeutics for neurotrauma
Xinyu Nie, Tianyang Yuan, Tong Yu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 5
The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications
William A. Banks, Elizabeth M. Rhea, May J. Reed, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101760-101760
Open Access | Times Cited: 5
Molecular dynamics of transferrin receptor binder peptides: unlocking blood-brain barrier for enhanced CNS drug delivery
Luiz Patrick Cordeiro Josino, Renan Patrick da Penha Valente, M.L. Silva, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-10
Closed Access
Stereoselectivity of evodiamine enantiomers in neuroprotective activity, pharmacokinetics and the ability across the blood-brain barrier
Ming Chen, Yiwen Zhang, Xin Qi, et al.
Journal of Chromatography A (2025) Vol. 1743, pp. 465658-465658
Closed Access
Intranasal administration of antiseizure drugs using new formulation trends: one step closer to reach clinical trials
Sara Meirinho, Márcio Rodrigues, Gilberto Alves
Expert Opinion on Drug Delivery (2025)
Closed Access
Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery
Ly Porosk, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 83-104
Closed Access
Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein
Marie‐Lynn Cuypers, Tom Jaspers, Jarne Clerckx, et al.
Fluids and Barriers of the CNS (2025) Vol. 22, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top